126 related articles for article (PubMed ID: 20692965)
21. Hepatoprotective activity of polyhydroxylated 2-styrylchromones against tert-butylhydroperoxide induced toxicity in freshly isolated rat hepatocytes.
Fernandes E; Carvalho M; Carvalho F; Silva AM; Santos CM; Pinto DC; Cavaleiro JA; de Lourdes Bastos M
Arch Toxicol; 2003 Sep; 77(9):500-5. PubMed ID: 12879211
[TBL] [Abstract][Full Text] [Related]
22. Selenoperoxidase-mediated cytoprotection against the damaging effects of tert-butyl hydroperoxide on leukemia cells.
Geiger PG; Lin F; Girotti AW
Free Radic Biol Med; 1993 Mar; 14(3):251-66. PubMed ID: 8458583
[TBL] [Abstract][Full Text] [Related]
23. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan SC; Girish C
Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
[TBL] [Abstract][Full Text] [Related]
24. A comparative study on the stability of silybin and that in silymarin in buffers and biological fluids.
Tang N; Wu D; Lu Y; Chen J; Zhang B; Wu W
Drug Metab Lett; 2009 Apr; 3(2):115-9. PubMed ID: 19601873
[TBL] [Abstract][Full Text] [Related]
25. Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin.
Tung NT; Tran CS; Nguyen HA; Nguyen TD; Chi SC; Pham DV; Bui QD; Ho XH
Int J Pharm; 2019 Jan; 555():63-76. PubMed ID: 30448315
[TBL] [Abstract][Full Text] [Related]
26. Activation of microsomal glutathione S-transferase in tert-butyl hydroperoxide-induced oxidative stress of isolated rat liver.
Aniya Y; Daido A
Jpn J Pharmacol; 1994 Sep; 66(1):123-30. PubMed ID: 7861657
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Bioavailability and Efficacy of Silymarin Solid Dispersion in Rats with Acetaminophen-Induced Hepatotoxicity.
Song IS; Nam SJ; Jeon JH; Park SJ; Choi MK
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33925040
[TBL] [Abstract][Full Text] [Related]
28. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation.
Tsai MJ; Liao JF; Lin DY; Huang MC; Liou DY; Yang HC; Lee HJ; Chen YT; Chi CW; Huang WC; Cheng H
Neurochem Int; 2010 Dec; 57(8):867-75. PubMed ID: 20868716
[TBL] [Abstract][Full Text] [Related]
29. Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury.
Farghali H; Kameniková L; Hynie S; Kmonicková E
Pharmacol Res; 2000 Feb; 41(2):231-7. PubMed ID: 10623491
[TBL] [Abstract][Full Text] [Related]
30. Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress.
Federico A; Dallio M; DI Fabio G; Zarrelli A; Zappavigna S; Stiuso P; Tuccillo C; Caraglia M; Loguercio C
In Vivo; 2015; 29(5):569-75. PubMed ID: 26359416
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients.
Schandalik R; Gatti G; Perucca E
Arzneimittelforschung; 1992 Jul; 42(7):964-8. PubMed ID: 1329780
[TBL] [Abstract][Full Text] [Related]
32. Silybin inhibits NLRP3 inflammasome assembly through the NAD
Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
[TBL] [Abstract][Full Text] [Related]
33. Effect of silybin on high-fat-induced fatty liver in rats.
Yao J; Zhi M; Minhu C
Braz J Med Biol Res; 2011 Jul; 44(7):652-9. PubMed ID: 21755261
[TBL] [Abstract][Full Text] [Related]
34. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
35. Cytoprotective effect of silybin against lasalocid-induced toxicity in HepG2 cells.
Radko L; Cybulski W; Rzeski W
Pol J Vet Sci; 2013; 16(2):275-82. PubMed ID: 23971195
[TBL] [Abstract][Full Text] [Related]
36. Silybin and silymarin--new and emerging applications in medicine.
Gazák R; Walterová D; Kren V
Curr Med Chem; 2007; 14(3):315-38. PubMed ID: 17305535
[TBL] [Abstract][Full Text] [Related]
37. Antioxidant activity of silybin in vivo during long-term iron overload in rats.
Pietrangelo A; Borella F; Casalgrandi G; Montosi G; Ceccarelli D; Gallesi D; Giovannini F; Gasparetto A; Masini A
Gastroenterology; 1995 Dec; 109(6):1941-9. PubMed ID: 7498660
[TBL] [Abstract][Full Text] [Related]
38. Primary cultures of human hepatocytes as a tool in cytotoxicity studies: cell protection against model toxins by flavonolignans obtained from Silybum marianum.
Dvorák Z; Kosina P; Walterová D; Simánek V; Bachleda P; Ulrichová J
Toxicol Lett; 2003 Feb; 137(3):201-12. PubMed ID: 12523963
[TBL] [Abstract][Full Text] [Related]
39. Effects of iron chelators and glutathione depletion on the induction and repair of chromosomal aberrations by tert-butyl hydroperoxide in cultured Chinese hamster cells.
Ochi T
Mutat Res; 1989 Aug; 213(2):243-8. PubMed ID: 2761558
[TBL] [Abstract][Full Text] [Related]
40. Anti-apoptotic defense of bcl-2 gene against hydroperoxide-induced cytotoxicity together with suppressed lipid peroxidation, enhanced ascorbate uptake, and upregulated Bcl-2 protein.
Saitoh Y; Ouchida R; Kayasuga A; Miwa N
J Cell Biochem; 2003 May; 89(2):321-34. PubMed ID: 12704795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
